Dexamethasone Sodium Phosphate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexamethasone Sodium Phosphate Injection (injection) from Mylan Institutional, a Viatris Company with status Current. The shortage was first posted on 02/08/2019.
Shortage Details
- Status
- Current
- Company
- Mylan Institutional, a Viatris Company
- Package NDC
- 67457-421-30
- Dosage Form
- Injection
- Presentation
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)
- Initial Posting
- 02/08/2019
- Revised Date